Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 275 Records) |
| Query Trace: Neoplasms and ROS1[original query] |
|---|
| Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations. ESMO open 2022 Dec 7 (6): 100742. Wang H-Y, Wu S-G, Lin Y-T, Chen C-Y, Shih J |
| Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan. JAMA network open 2022 12 5 (12): e2245081. Naito Yoichi, Sunami Kuniko, Kage Hidenori, Komine Keigo, Amano Toraji, Imai Mitsuho, Koyama Takafumi, Ennishi Daisuke, Kanai Masashi, Kenmotsu Hirotsugu, Maeda Takahiro, Morita Sachi, Sakai Daisuke, Watanabe Kousuke, Shirota Hidekazu, Kinoshita Ichiro, Yoshioka Masashiro, Mamesaya Nobuaki, Ito Mamoru, Kohsaka Shinji, Saigusa Yusuke, Yamamoto Kouji, Hirata Makoto, Tsuchihara Katsuya, Yoshino Takayu |
| Actionable mutations in non-small cell lung cancer in patients at hospital de Especialidades Eugenio Espejo, Ecuador 2017-2020. Drug metabolism and personalized therapy 2022 12 . Fernández Freire Miguel Ángel, Gálvez Salazar Gabriela Isabel, Scudeler Mariana Meira, Rodrigues-Soares Fernanda, Jaramillo Koupermann Gabriela Fernanda, Moreno Ocampo Andrea Pao |
| Budget impact analysis of next-generation sequencing versus sequential single-gene testing in Japanese patients with advanced non-small-cell lung cancer. Respiratory investigation 2022 12 61 (1): 61-73. Matsuda Hiroyuki, Ogawa Toru, Sadatsuki Yasunari, Tsujino Toshiaki, Wada Shingo, Kim Seok-Won, Hatanaka Yuta |
| Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis. Frontiers in oncology 2022 12 12 1030786. Andrikopoulou Angeliki, Zografos Eleni, Apostolidou Kleoniki, Kyriazoglou Anastasios, Papatheodoridi Alksistis-Maria, Kaparelou Maria, Koutsoukos Konstantinos, Liontos Michalis, Dimopoulos Meletios-Athanasios, Zagouri Flo |
| Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 12 . Ernst Sophie M, Mankor Joanne M, van Riet Job, von der Thüsen Jan H, Dubbink Hendrikus J, Aerts Joachim G J V, de Langen Adrianus J, Smit Egbert F, Dingemans Anne-Marie C, Monkhorst K |
| Concurrent classic driver oncogenes mutation with ROS1 rearrangement predicts superior clinical outcome in NSCLC patients. Genes & genomics 2022 11 45 (1): 93-102. Li Dandan, Jiang Hua, Jin Faguang, Pan Lei, Xie Yonghong, Zhang Liang, Li Chunm |
| ALK, ROS1, RET and NTRK1-3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers. International journal of molecular sciences 2023 9 24 (17): . Rimma S Mulkidjan, Evgeniya S Saitova, Elena V Preobrazhenskaya, Karimat A Asadulaeva, Mikhail G Bubnov, Ekaterina A Otradnova, Darya M Terina, Sofia S Shulga, Darya E Martynenko, Maria V Semina, Evgeniya V Belogubova, Vladislav I Tiurin, Priscilla S Amankwah, Aleksandr S Martianov, Evgeny N Imyanit |
| Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer. Internal medicine journal 2023 9 . Udit Nindra, Abhijit Pal, Victoria Bray, Po Y Yip, Annette Tognela, Tara L Roberts, Therese M Becker, Jonathon Williamson, Mahtab Farzin, Jing J Li, Vivienne Lea, Abeer Hagelamin, Weng Ng, Bin Wang, C Soon Lee, Wei Ch |
| Compromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data. JCO oncology practice 2023 8 OP2200611. Jeffrey A Scott, Jochen Lennerz, Melissa Lynne Johnson, Lucio N Gordan, Robert H Dumanois, Luca Quagliata, Lauren L Ritterhouse, Federico Cappuzzo, Brandon Wang, Mei Xue, Anupama Vasudevan, Prateesh Varughese, Varun Vaidya, Mike Gart, Natalie Dorrow, Hinco J Gierman, Rushir J Chok |
| Genome-wide Detection of Chimeric Transcripts in Early-stage Non-small Cell Lung Cancer. Cancer genomics & proteomics 2023 8 20 (5): 417-432. Yaroslav Ilnytskyy, Lars Petersen, John B McIntyre, Mie Konno, Adrijana D'Silva, Michelle Dean, Anifat Elegbede, Andrey Golubov, Olga Kovalchuk, Igor Kovalchuk, Gwyn Be |
| Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications. Lung cancer (Amsterdam, Netherlands) 2023 8 184 107317. Huriye Seker-Cin, Timothy Kwang Yong Tay, Daniel Kazdal, Klaus Kluck, Markus Ball, Olaf Neumann, Hauke Winter, Felix Herth, Claus-Peter Heußel, Rajkumar Savai, Peter Schirmacher, Michael Thomas, Jan Budczies, Michael Allgäuer, Petros Christopoulos, Albrecht Stenzinger, Anna-Lena Volckm |
| Comparing Fractionated and Single-Fraction Gamma Knife Radiosurgery for Brain Metastases From Non-Small-Cell Lung Cancer With a Focus on Driver Alterations. Cureus 2023 8 15 (7): e41849. Mariko Kawashima, Atsuya Akabane, Ryuichi Noda, Masafumi Segawa, Sho Tsunoda, Tomohiro Ino |
| EGFR co-mutation is associated with the risk of recurrence in invasive lung adenocarcinoma with the micropapillary component. Asian journal of surgery 2023 8 . Haixin Kang, Haiyan Lv, Tao-Hsin Tung, Dehua Ma, Zheng Wang, Juping Du, Kai Zhou, Juan Pan, Yanjie Zhang, Shuotao Peng, Zhaonan Yu, Bo Shen, Minhua |
| Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma. Cancer genomics & proteomics 2023 7 20 (4): 404-411. Vlastimil Kulda, Jiri Polivka, Martin Svaton, Tomas Vanecek, Marcela Buresova, Katerina Houfkova, Mahyar Sharif Bagheri, Tereza Knizkova, Bohuslava Vankova, Jindra Windrichova, Petr Macan, Vaclav Babuska, Martin Pes |
| Importance of ROS1 gene fusions in non-small cell lung cancer. Cancer drug resistance (Alhambra, Calif.) 2023 7 6 (2): 332-344. Meri Muminovic, Carlos Rodrigo Carracedo Uribe, Andres Alvarez-Pinzon, Khine Shan, Luis E Ra |
| Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer. Medicine 2023 6 102 (26): e34143. Yin JiaXin, Cong XiaoFeng, Cui PengFei, Zhao Songchen, Liu Zili |
| Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations. Cancer research communications 2023 6 3 (6): 1026-1040. Kazunori Aoki, Yukari Nishito, Noriko Motoi, Yasuhito Arai, Nobuyoshi Hiraoka, Tatsuhiro Shibata, Yukiko Sonobe, Yoko Kayukawa, Eri Hashimoto, Mina Takahashi, Etsuko Fujii, Takashi Nishizawa, Hironori Fukuda, Kana Ohashi, Kosuke Arai, Yukihiro Mizoguchi, Yukihiro Yoshida, Shun-Ichi Watanabe, Makiko Yamashita, Shigehisa Kitano, Hiromi Sakamoto, Yuki Nagata, Risa Mitsumori, Kouichi Ozaki, Shumpei Niida, Yae Kanai, Akiyoshi Hirayama, Tomoyoshi Soga, Toru Maruyama, Keisuke Tsukada, Nami Yabuki, Mei Shimada, Takehisa Kitazawa, Osamu Natori, Noriaki Sawada, Atsuhiko Kato, Teruhiko Yoshida, Kazuki Yasuda, Hideaki Mizuno, Hiroyuki Tsunoda, Atsushi Ochi |
| Significance of the FGFR3 mutation in Chinese patients with bladder cancer. Translational andrology and urology 2023 6 12 (5): 761-769. Lanxiang Hao, Jiang Fang, Ran Xu, Shuo Liu, Guangcheng Luo, Xinjun Wa |
| [Clinicopathological analysis of 4 cases of lung cancer with concomitant EGFR mutation and ROS1 fusion]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2023 6 52 (6): 615-617. M H Yao, Y H Ya |
| The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature 2023 4 616 (7957): 525-533. Frankell Alexander M, Dietzen Michelle, Al Bakir Maise, Lim Emilia L, Karasaki Takahiro, Ward Sophia, Veeriah Selvaraju, Colliver Emma, Huebner Ariana, Bunkum Abigail, Hill Mark S, Grigoriadis Kristiana, Moore David A, Black James R M, Liu Wing Kin, Thol Kerstin, Pich Oriol, Watkins Thomas B K, Naceur-Lombardelli Cristina, Cook Daniel E, Salgado Roberto, Wilson Gareth A, Bailey Chris, Angelova Mihaela, Bentham Robert, Martínez-Ruiz Carlos, Abbosh Christopher, Nicholson Andrew G, Le Quesne John, Biswas Dhruva, Rosenthal Rachel, Puttick Clare, Hessey Sonya, Lee Claudia, Prymas Paulina, Toncheva Antonia, Smith Jon, Xing Wei, Nicod Jerome, Price Gillian, Kerr Keith M, Naidu Babu, Middleton Gary, Blyth Kevin G, Fennell Dean A, Forster Martin D, Lee Siow Ming, Falzon Mary, Hewish Madeleine, Shackcloth Michael J, Lim Eric, Benafif Sarah, Russell Peter, Boleti Ekaterini, Krebs Matthew G, Lester Jason F, Papadatos-Pastos Dionysis, Ahmad Tanya, Thakrar Ricky M, Lawrence David, Navani Neal, Janes Sam M, Dive Caroline, Blackhall Fiona H, Summers Yvonne, Cave Judith, Marafioti Teresa, Herrero Javier, Quezada Sergio A, Peggs Karl S, Schwarz Roland F, Van Loo Peter, Miedema Daniël M, Birkbak Nicolai J, Hiley Crispin T, Hackshaw Allan, Zaccaria Simone, , Jamal-Hanjani Mariam, McGranahan Nicholas, Swanton Charl |
| Molecular genetics of diffuse sclerosing papillary thyroid cancer. The Journal of clinical endocrinology and metabolism 2023 3 . Alswailem Meshael, Alghamdi Balgees, Alotaibi Anwar, Aljomiah Abeer, Al-Hindi Hindi, Murugan Avaniyapuram Kannan, Abouelhoda Mohamed, Shi Yufei, Alzahrani Ali |
| Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With ROS1-Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort Study. JCO precision oncology 2023 3 7 e2200614. Huang Zhe, Yan Huan, Zeng Liang, Xu Qinqin, Guo Wenhuan, Lin Shaoding, Jiang Wenjuan, Wang Zhan, Deng Li, Qin Haoyue, Zhang Xing, Tong Fan, Zhang Ruiguang, Liu Zhaoyi, Zhang Lin, Dong Xiaorong, Yang Nong, Zhang Yongcha |
| Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer. Cancer research and treatment 2023 3 . Lee Dae-Won, Lim Yoojoo, Kim Hwang-Phill, Kim Su Yeon, Roh Hanseong, Kang Jun-Kyu, Lee Kyung-Hun, Kim Min Jung, Ryoo Seung-Bum, Park Ji Won, Jeong Seung-Yong, Park Kyu Joo, Kang Gyeong Hoon, Han Sae-Won, Kim Tae-Y |
| Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data. Frontiers in immunology 2023 3 14 1090838. Li Mengyuan, Gao Xuejiao, Wang Xiaoshe |
| Application of the Novel Grading System of Invasive Pulmonary Adenocarcinoma in a Real Diagnostic Scenario: A Brief Report of 9353 Cases. JTO clinical and research reports 2023 3 4 (3): 100465. She Yunlang, Zhong Yifan, Hou Likun, Zhao Shengnan, Zhang Liping, Xie Dong, Zhu Yuming, Wu Chunyan, Chen Cha |
| ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing. Gynecologic oncology 2023 2 171 59-66. Machida Hiroko, Matsuo Koji, Tanaka Masayuki, Kitatani Kanae, Takase Akinori, Yokoyama Keiko, Kajiwara Hiroshi, Yasaka Miwa, Ikeda Masae, Yoshida Hiroshi, Hirasawa Takeshi, Mikami Mik |
| Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018. European journal of cancer (Oxford, England : 1990) 2023 2 183 38-48. Bylicki Olivier, Tomasini Pascale, Radj Gervais, Guisier Florian, Monnet Isabelle, Ricordel Charles, Bigay-Game Laurence, Geier Margaux, Chouaid Christos, Daniel Catherine, Swalduz Aurelie, Toffart Anne-Claire, Doubre Helene, Peloni Jean-Michel, Moreau Diane, Subtil Fabien, Grellard Jean-Michel, Castera Marie, Clarisse Benedicte, Martins-Lavinas Pedro-Henrique, Decroisette Chantal, Greillier Laurent, |
| Molecular characteristics and prognostic factors of leptomeningeal metastasis in non-small cell lung cancer. Clinical neurology and neurosurgery 2023 1 225 107572. Liu Xiaocui, Li Guangrui, Zhang Hongmei, Chang Qing, Fang Mei, Lu Chufan, Tian Panpan, Mei Fengj |
| Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer. Medicine 2023 1 102 (4): e32781. Li Fanghua, Yang Yue, Xu Ying, Li Ke, Song Linhong, Xue Yang, Dong Dand |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: